SCHEMBL20656177

SCHEMBL20656177

OCc1ccsc1-c1cccc2c(-c3sccc3CO)cccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.39
PDCD1 Q15116 2/20 0.37
CD274 Q9NZQ7 2/20 0.37
PARP1 P09874 1/20 0.36
PTGS1 P23219 1/20 0.36
PTPRC P08575 1/20 0.35
PABPC1 P11940 1/20 0.34
DNMT1 P26358 1/20 0.34
TP53 P04637 2/20 0.34
KMT2A Q03164 2/20 0.34
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34
CES1 P23141 1/20 0.32
MAPT P10636 2/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
TSHR P16473 1/20 0.32
ALOX12 P18054 1/20 0.32
ADRA2A P08913 1/20 0.31
ADRA2B P18089 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28764676 0.80 DPP4 (0.48) CYP2A6PDCD1CD274PTGS1PTPRC
SCHEMBL10473041 0.78 CYP2A6 (0.58) CYP2A6MAPTALDH1A1
SCHEMBL27691517 0.77 ESR2 (0.45) CYP2A6PTGS1PTPRCKMT2AMAPT
SCHEMBL8573654 0.76 DPP4 (0.41) PTGS1KMT2ACES1MAPTKDM4E
SCHEMBL8193897 0.76 CTSA (0.39) CYP2A6KMT2AMAPK1MAPTKDM4E
SCHEMBL5111011 0.75 TP53 (0.57) CYP2A6PDCD1CD274PTGS1TP53
SCHEMBL20991154 0.72 KLF10 (0.34) CYP2A6PTGS1TP53KMT2AALOX15
SCHEMBL10550712 0.72 DPP4 (0.41) PTGS1KMT2ACES1MAPTKDM4E
SCHEMBL5954368 0.71 PTGS1 (0.36) CYP2A6PTGS1TP53KMT2AALOX15
SCHEMBL10846409 0.70 PDCD1 (0.34) PDCD1CD274PTGS1ADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200165266-A1 RING CLOSURE REACTION FLEXENABLE LIMITED (GB) 2020-05-28 US disclosed
WO-2019011826-A1 RING CLOSURE REACTION MERCK PATENT GMBH (DE) 2019-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200165266-A1 RING CLOSURE REACTION LIG4, ATG7, RNF4 CYP2A6 553/4885PDCD1 1599/4885CD274 2198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.